Introduction: historical perspective and development of amoxicillin/clavulanate

International Journal of Antimicrobial Agents

Volumn 30, Issue SUPPL. 2, 2007, Pages 109-112

  Geddes, Alasdair M ^a   Klugman, Keith P ^b,c   Rolinson, George N ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amoxicillin clavulanic acid; Antibiotic resistance; Beta lactamase; History of medicine; Penicillin

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZLOCILLIN; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBENICILLIN; CEFALORIDINE; CEFALOTIN; CEPHALOSPORIN; CHLORAMPHENICOL; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCLOXACILLIN; KANAMYCIN; METICILLIN; METRONIDAZOLE; MEZLOCILLIN; PENICILLIN G; PENICILLIN V; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BONE MARROW APLASIA; DRUG ACTIVITY; DRUG FORMULATION; DRUG MEGADOSE; DRUG STRUCTURE; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; NEPHROTOXICITY; NEUROPATHY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HISTORY, 20TH CENTURY; HUMANS;

EID: 36148995090     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.015     Document Type: Article

References (12)

1. WHO World Health Report 2005. http://www.who.int/whr/2005/annexes-en.pdf.
2. WHO World Health Report 2004. http://www.who.int/whr/2004/annex/en/index.htm.
3. Garrod L.P. Antibiotics versus staphylococci. Br Med J 2 (1956) 217
4. Ehrlich P. Chemotherapeutics: scientific principles, methods and results. Lancet 2 (1913) 445-451
5. WHO. Drug resistance threatens to reverse medical progress (2000), WHO Press release
6. Rolinson G.N. 6-APA and the development of the beta-lactam antibiotics. J Antimicrob Chemother 5 (1979) 7-14
7. Rolinson G.N. Forty years of beta-lactam research. J Antimicrob Chemother 41 (1998) 589-603
8. Rolinson G.N., and Geddes A.M. The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA). Int J Antimicrob Agents 29 (2007) 3-8
9. Sutherland R., Croydon E.A.P., and Rolinson G.N. Amoxycillin: a new semi-synthetic penicillin. Br Med J 3 (1972) 13-16
10. White A.R., Kaye C., Poupard J., Pypstra R., Woodnutt G., and Wynne B. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother 53 Suppl S1 (2004) i3-i20
11. Datta N., and Kontomichalou P. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature 208 (1968) 239-241
12. Reading C., and Cole M. Clavulanic acid: a beta-lactamase inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother 11 (1977) 852-857